Regeneron Pharmaceuticals, Inc. (REGN)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
544.10-4.10 (-0.75%)
At close: 4:00PM EST
543.95 -0.15 (-0.03%)
Before hours: 9:26AM EST
| Previous close | 548.20 |
| Open | 558.91 |
| Bid | 544.00 x 1000 |
| Ask | 544.00 x 1100 |
| Day's range | 542.14 - 556.95 |
| 52-week range | 328.13 - 664.64 |
| Volume | 901,677 |
| Avg. volume | 934,877 |
| Market cap | 58.059B |
| Beta (5Y monthly) | 0.30 |
| PE ratio (TTM) | 19.94 |
| EPS (TTM) | 27.29 |
| Earnings date | 05 Feb 2021 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 660.56 |
- Editor's pickYahoo Finance
Coronavirus update: J&J to release vaccine data next week; strain from Brazil confirmed in US
Johnson and Johnson expects vaccine data next week.
- PR Newswire
REGEN-COV™ Antibody Cocktail Is Active Against SARS-CoV-2 Variants First Identified in the UK and South Africa
Columbia University researchers and Regeneron have independently confirmed findings; data included in bioRxiv paper and submitted for peer-reviewed publication
- Motley Fool
2 Best Pharma Stocks to Buy Right Now
Investors will want to scoop up shares of this diversified drugmaker and coronavirus vaccine developer before it's too late.
© 2021 Verizon Media. All rights reserved.
